BioLife Solutions, Inc.

54
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US09062W2044
USD
25.83
0.46 (1.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
BioLife Solutions, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-11.00
-18.00
-144.00
-29.00
0.00
-3.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
1.00
-14.00
-2.00
-1.00
-4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
8.00
-12.00
-8.00
-4.00
6.00
1.00
Cash Flow from Investing Activities
58.00
17.00
-58.00
-13.00
-24.00
-27.00
Cash Flow from Financing Activities
-6.00
10.00
16.00
-2.00
102.00
1.00
Net Cash Inflow / Outflow
59.00
15.00
-50.00
-20.00
84.00
-24.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of BioLife Solutions, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-11.425
-55.743
44.00
79.50%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.227
-13.913
13.00
101.63%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
8.431
-32.014
40.00
126.34%
Cash Flow from Investing Activities
58.3
-7.176
65.00
912.43%
Cash Flow from Financing Activities
-6.783
3.887
-9.00
-274.50%
Net Cash Inflow / Outflow
59.948
-35.303
94.00
269.81%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 167.46% vs -47.24% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
8.43
-12.50
167.46%